Loading clinical trials...

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00989014

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

This is a randomized, double-blind, parallel-group, vehicle-controlled, dose-finding study to investigate the pharmacodynamics and the safety of three dosages of CD07805/47 topical gel (0.07%, 0.18%, ...

Lead sponsor: Galderma R&D•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

NCT02393937 · Papulopustular Rosacea, Erythematotelangiectatic Rosacea

COMPLETEDNA

Feasibility Study: Ulthera System for the Treatment of Rosacea

NCT01756027 · Erythematotelangiectatic Rosacea

COMPLETEDPhase 2

Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

NCT02052999 · Erythematotelangiectatic Rosacea, Papulopustular Rosacea

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 18, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment122

Start dateSep 2009

Last updatedFeb 18, 2021

Condition

Erythematotelangiectatic Rosacea

Locations shown

Burke Pharmaceutical Research

Hot Springs, Arkansas

Philadephia Institute of Dermatology

Fort Washington, Pennsylvania

Derm Research, Inc

Austin, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 18, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions